Articles by Jordana Jampel
The trial drug revealed greater reductions in 24-hour average blood pressure than placebo.
Researchers have begun to uncover the circadian rhythm of myocardial infarction severity.
The newly approve products include four new sizes.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
Researchers aimed to determine whether a two-pill antihypertensive strategy is effective at controlling hypertension.
Exposures included missense variants in TRR associated with increasing transthyretin tetramer destabilization.
Pulsatility index and transfer function gain were calculated.
Researchers explored how immune checkpoint inhibitors interact with immune cells in arterial plaques.
Researchers were able to capture the more intricate multidimensional aspects of heart shape genomics.
The findings suggest that around 10.5 hours of sedentary behavior per day was significantly linked with future heart failure.
Past data from 1990-2021 and 2050 forecasts on prevalence of obesity or overweight have been published in The Lancet.
Researchers pinpointed factors in the blood that may indicate whether a patient’s myocarditis is likely to lead to ...
The 2024 joint AHA/ACC guideline on cardiovascular risk management for patients undergoing noncardiac surgery is here.
CLEAR SYNERGY is the largest trial to date on colchicine treatment in myocardial infarction.
In approximately 50% of patients, pulmonary vein isolation (PVI) successfully treats persistent AFib at one year.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.